| Economic assessment of doripenem versus imipenem in the treatment of ventilator-associated pneumonia. | |
| | |
MedLine Citation:
|
PMID: 20136579 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
BACKGROUND: Ventilator-associated pneumonia (VAP), the most common nosocomial infection in critically ill patients, is associated with significantly longer duration of mechanical ventilation, and increased mortality, hospital days, and health-care costs. A previously published prospective, randomized study established the noninferiority of intravenous (IV) doripenem versus IV imipenem/cilastatin ('imipenem') for VAP. This study compares the economic outcomes of IV therapy with doripenem versus imipenem as first-line treatment for VAP. METHODS: A decision-analytic model of inpatient care and outcomes for VAP was used to estimate costs associated with VAP treatment. The model calculates total hospital costs, comprising costs of initial and concomitant therapy, and costs associated with mechanical ventilation, intensive care unit stays, and total days in hospital. RESULTS: Total treatment costs for doripenem were $10,630 lower than for imipenem ($71,259 vs. 81,889), driven primarily by differences in costs of mechanical ventilation ($45,224 for doripenem, $57,348 for imipenem). Probabilistic sensitivity analyses found doripenem consistently cost saving versus imipenem in 1,000 simulations. Study limitations include use of a simple model to represent a complex disease process and reliance on trial data that may not reflect real-world care and outcomes. CONCLUSIONS: Doripenem is a cost saving first-line treatment for VAP versus imipenem while providing an equivalent rate of cure. |
| | |
Authors:
|
Lisa J McGarry; Sanjay Merchant; Dilip Nathwani; Vivek Pawar; Kelly DeLong; David Thompson; Kasem Akhras; Michael Ingham; Milton C Weinstein |
Related Documents
:
|
22399359 - Hospitalisations and costs relating to ambulatory care sensitive conditions in ireland. 10166279 - How much does excess inpatient capacity really cost? 10249369 - Energy conservation: when the bill is in millions. 10134769 - Using benchmarking techniques to improve efficiency and quality in cardiology services:... 14691429 - Cost of care distribution in atrial fibrillation patients: the cocaf study. 20123669 - Costs of inpatient care among medicare beneficiaries with heart failure, 2001 to 2004. 18215259 - Conditions for parents' participation in the care of their child in neonatal intensive ... 22334799 - Experience of being a low priority patient during waiting time at an emergency department. 18339949 - Faculty expectations of veterinary students in clinical rotations. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of medical economics Volume: 13 ISSN: 1941-837X ISO Abbreviation: J Med Econ Publication Date: 2010 Mar |
Date Detail:
|
Created Date: 2010-02-17 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9892255 Medline TA: J Med Econ Country: England |
Other Details:
|
Languages: eng Pagination: 142-7 Citation Subset: IM |
Affiliation:
|
i3 Innovus, 10 Cabot Road, Medford, MA 02155, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Renal function changes and NHS resource use in breast cancer patients with metastatic bone disease t...
Next Document: The cost-effectiveness of somatropin treatment for short children born small for gestational age (SG...